Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-28 1:54 pm Sale | 2021-12-31 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 199,976 13.500% | -976 (-0.49%) | Filing History |
| 2021-10-21 4:15 pm Purchase | 2021-10-20 | 13G | Cara Therapeutics, Inc. CARA | Vifor (International) Ltd. | 205,466 13.900% | 91,178 (+79.78%) | Filing History |
| 2021-05-07 5:09 pm Purchase | 2021-04-30 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 200,952 14.500% | 100,056 (+99.17%) | Filing History |
| 2021-02-16 2:41 pm Purchase | 2020-12-31 | 13G | Cara Therapeutics, Inc. CARA | FIRST MANHATTAN CO. LLC. | 89,244 6.450% | 89,244 (New Position) | Filing History |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | Cara Therapeutics, Inc. CARA | T. Rowe Price Associates, Inc. | 67,479 4.800% | -61,983 (-47.88%) | Filing History |
| 2021-02-12 3:42 pm Sale | 2020-12-31 | 13G | Cara Therapeutics, Inc. CARA | RHO Ventures VI LP | 77,752 5.600% | -10,944 (-12.34%) | Filing History |
| 2021-01-28 5:56 pm Purchase | 2020-12-31 | 13G | Cara Therapeutics, Inc. CARA | BlackRock Inc. BLK | 100,896 7.300% | 2,388 (+2.42%) | Filing History |
| 2020-10-23 4:05 pm Purchase | 2020-10-15 | 13G | Cara Therapeutics, Inc. CARA | Vifor (International) Ltd. | 114,288 8.300% | 114,288 (New Position) | Filing History |